BioArctic
Develops treatments and diagnostics for neurodegenerative disorders like Alzheimer's and Parkinson's.
BIOA | ST
Overview
Corporate Details
- ISIN(s):
- SE0010323303 (+1 more)
- LEI:
- 549300Y0OI2WVUNHLC33
- Country:
- Sweden
- Address:
- Warfvinges väg 35, 112 51 Stockholm
- Website:
- https://www.bioarctic.se/en/
Description
BioArctic is a Swedish research-intensive biopharmaceutical company focused on developing novel, disease-modifying treatments and diagnostics for neurodegenerative disorders. The company's core mission is to address the underlying causes of diseases such as Alzheimer's and Parkinson's. Its research is centered on developing innovative drugs and antibodies that target the root mechanisms of nerve cell damage and misfolded proteins, aiming to provide effective solutions for significant unmet medical needs within the central nervous system.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2018-10-21 09:00 |
BioArctic is granted a concept patent in Europe for the company’s strategy for …
|
English | 183.3 KB | ||
| 2018-10-03 14:30 |
BioArctic får patentskydd i Europa för en medicinteknisk produkt för behandling…
|
Swedish | 187.7 KB | ||
| 2018-10-03 14:30 |
BioArctic receives European patent protection for a medical device for treatmen…
|
English | 188.6 KB | ||
| 2018-09-13 10:00 |
BioArctic ingår forskningssamarbete med Brain Biomarker Solutions in Gothenburg…
|
Swedish | 218.8 KB | ||
| 2018-09-13 10:00 |
BioArctic signs a research agreement with Brain Biomarker Solutions in Gothenbu…
|
English | 189.1 KB | ||
| 2018-09-03 14:30 |
BioArctic utvidgar forskningssamarbetet med Uppsala universitet kring antikropp…
|
Swedish | 184.6 KB | ||
| 2018-09-03 14:30 |
BioArctic expands the research collaboration with Uppsala University concerning…
|
English | 185.7 KB | ||
| 2018-08-23 08:00 | Swedish | 575.5 KB | |||
| 2018-08-23 08:00 | English | 579.1 KB | |||
| 2018-08-14 08:00 |
Invitation to presentation of BioArctic’s Interim Report for the period January…
|
English | 178.1 KB | ||
| 2018-08-14 08:00 |
Inbjudan till presentation av BioArctics delårsrapport för perioden januari – j…
|
Swedish | 174.5 KB | ||
| 2018-08-07 20:00 |
BioArctic obtains exclusive rights to develop antibody treatments for Alzheimer…
|
English | 195.0 KB | ||
| 2018-08-07 20:00 |
BioArctic erhåller exklusiva rättigheter till att utveckla antikroppsbehandling…
|
Swedish | 184.9 KB | ||
| 2018-07-25 22:30 |
BioArctic meddelar detaljerade resultat från Fas 2b-studien med BAN2401 i tidig…
|
Swedish | 214.4 KB | ||
| 2018-07-25 22:30 |
BioArctic announces detailed results of the BAN2401 Phase 2b study in early Alz…
|
English | 217.7 KB |
Automate Your Workflow. Get a real-time feed of all BioArctic filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioArctic
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioArctic via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-13 | Gunilla Osswald | Other | Sell | 40,000 | 8,821,200.00 SEK |
| 2025-02-13 | Gunilla Osswald | Other | Other | 40,000 | 3,344,000.00 SEK |
| 2025-02-13 | Sten Mikael Moge | Other | Sell | 6,000 | 1,323,180.00 SEK |
| 2025-02-13 | Sten Mikael Moge | Other | Other | 6,000 | 501,600.00 SEK |
| 2025-02-13 | Johanna Margareta Fälting | Other | Sell | 1,500 | 330,795.00 SEK |
| 2025-02-13 | Johanna Margareta Fälting | Other | Other | 2,500 | 209,000.00 SEK |
| 2025-02-13 | Johanna Margareta Fälting | Other | Other | 1,500 | 125,400.00 SEK |
| 2025-01-10 | Mikael Smedeby | Other | Buy | 730 | 148,920.00 SEK |
| 2024-12-19 | Oskar Bosson | Other | Sell | 2,000 | 446,000.00 SEK |
| 2024-12-19 | Oskar Bosson | Other | Sell | 871 | 195,626.60 SEK |
Peer Companies
